🇸🇬 Augtyro in Singapore

Augtyro (REPOTRECTINIB) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Augtyro in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Augtyro approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Augtyro in Singapore?

Bristol is the originator. The local marketing authorisation holder may differ — check the official source linked above.